MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis.
MFAP4 是胶质瘤中一种新型的预后生物标志物,与免疫疗法耐药性和铁死亡相关
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1551863
Lv Yuanhao, Gao Ying, Di Wenyu, Li Zhaoyi, Shi Yashen, Hou Tianyuan, Chen Yiyang, Tian Jiaqi, Xu Miaoming, Su Wei, Zhang Min, Zhong Jiateng